Accordingly, PI3K inhibition by LY294002 broadly sensitized wild-type and mutant PTEN glioblastoma cells to death receptor-induced apoptosis following treatment with TRAIL or agonistic anti-CD95 antibodies as well as to chemotherapy-induced apoptosis in a highly synergistic manner36. Here, TNFSF10 is linked to glioblastoma.